Viral FLIPping Autophagy for Longevity  by Liang, Chengyu
Cell Host & Microbe
PreviewsViral FLIPping Autophagy for LongevityChengyu Liang1,*
1Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA 90033, USA
*Correspondence: chengyu.liang@usc.edu
DOI 10.1016/j.chom.2012.01.012
Tumor-causing g-herpesviruses have evolved elaborate mechanisms to deal with almost every aspect of
host cell defense. In this issue of Cell Host & Microbe, Leidal et al. (2012) report an oncogenic synergy
between the latent KSHV proteins v-FLIP and v-cyclin during KSHV persistent infection that reshapes
autophagy.Initially discovered as a cellular response
to adapt to nutrient deficiency, macroau-
tophagy (hereafter referred to as auto-
phagy) has since been recognized as
a highly conserved signaling system that
patrols diverse growth, differentiation,
and homeostatic processes (Levine and
Kroemer, 2008; Yang and Klionsky,
2010). During autophagy, intracellular
cargoes are subjected to lysosome-
directed transportation and degradation
in double membrane-bound autophago-
somes (Yang and Klionsky, 2010). In the
absence of stimuli, autophagy remains
latent to maintain a relatively stable intra-
cellular milieu. When cells experience
various stress conditions, autophagy is
activated, triggering responses that alle-
viate stress, repair cellular damage (e.g.,
organelle, protein, and/or DNA damage),
or eliminate affected cells via so-called
autophagic cell death (Levine and
Kroemer, 2008). Furthermore, recent
evidence places autophagy within the
heart of the cellular senescence program
evoked by the oncoprotein RAS and
shows that autophagy is one of its down-
stream effector pathways (Young et al.,
2009). Hence, stressed tumor cells that
hijack autophagy for survival may alterna-
tively or additionally run the risk of
terminal growth arrest. Clearly, such
protective autophagic responses do not
favor tumor expansion.
Autophagy also limits pathogen
survival. Autophagic processing delivers
signals for viral recognition, interferon
production, and antigen presentation. In
turn, viruses have devised elegant strate-
gies to co-opt the cellular autophagy
pathway to guarantee their invasion,
survival, and propagation. This is particu-
larly the case for the ubiquitous and
persistent herpesvirus infections, where
the interplay between herpesviruses andhost cell autophagy is a constant battle
for control (Shoji-Kawata and Levine,
2009).
g-Herpesviruses, exemplified by Kapo-
si’s sarcoma-associated herpesvirus
(KSHV), are sophisticated oncogenic
viruses that establish lifelong latency in
lymphoid or endothelial cells. These
viruses can reactivate, sometimes fre-
quently, to cause recurrent disease and
virus spreading, without being cleared
by the host immune system (Ganem,
2010). One critical virulence factor for
KSHV latency and oncogenicity is the viral
homolog of cellular FLIPs (referred to as
v-FLIP). Like its cellular counterpart
(FLIP), v-FLIP was originally described to
inhibit Fas-mediated caspase activation.
Yet the current view of v-FLIP focuses
on its ability to mobilize the NF-kB
pathway in KSHV latently infected cells,
giving these cells a survival advantage
and inducing endothelial cell spindling
(Ganem, 2010). However, more recent
investigations have shown that v-FLIP
also plays a critical role in concomitantly
blocking cellular autophagy, whereby
v-FLIP targets the autophagy effector
Atg3 and impairs elongation of the auto-
phagosome membrane, thus inhibiting
autophagy in a manner more potently
than cellular FLIP (Lee et al., 2009). Since
autophagy is key to clearing the intracel-
lular environment, this property of v-FLIP
may tilt the homeostatic balance in favor
of viral chronic infection and/or pathogen-
esis. Yet despite these advances in our
understanding of the molecular biology
of v-FLIP, the precise role of v-FLIP-medi-
ated antiautophagy during KSHV infection
remains, at least for the moment,
unknown. Additionally, v-FLIP is known
to share the same set of transcripts with
two other latent gene products, viral cy-
clin (v-cyclin), which is a viral homolog ofCell Host & Microbe 11,cellular D-type cyclins and drives cell
proliferation, and the latency-associated
nuclear antigen (LANA), a multifunctional
protein that modulates viral and cellular
gene expression and helps maintain viral
episomes. Together, v-FLIP, v-cyclin,
and LANA comprise the so-called ‘‘onco-
genic cluster’’ of KSHV and are thought to
be necessary for viral-mediated transfor-
mation through their coordinated expres-
sion. How this oncogenic network is
wired in favor of viral latency remains
largely unknown. An exciting report by
McCormick and colleagues in this issue
of Cell Host & Microbe sheds light on the
matter, identifying an oncogenic coopera-
tion between v-FLIP and v-cyclin in KSHV
infection: v-cyclin steers cell proliferation
whereas v-FLIP counteracts senescence
induced by v-cyclin by inhibiting auto-
phagy (Leidal et al., 2012). This observa-
tion highlights the synergy of two crucial
latent factors in KSHV pathology while
also providing a mechanistic explanation
for autophagy evasion during latent infec-
tion of KSHV.
One major barrier to the expansion of
abnormal cells with significant replicative
potential is the induction of cellular senes-
cence, or so-called ‘‘oncogene-induced
senescence’’ (OIS) (Gorgoulis and Hala-
zonetis, 2010). Recent work has discov-
ered that, despite increased cell prolifera-
tion, KSHV v-cyclin-transfected cells are
in fact treading on thin ice. They appear
to be highly sensitive to senescence,
a process that relies on intact DNA
damage responses (DDRs) and subse-
quent activation of the tumor suppressor
protein p53 (Koopal et al., 2007). Given
these findings, Leidal et al. were intrigued
by their observation that KSHV infection
of cultured cells, whereby latency is
the default program, results in potent
cellular DDRs—as expected—but not inFebruary 16, 2012 ª2012 Elsevier Inc. 101
Figure 1. Oncogenic Synergy of v-FLIP and v-Cyclin onCellular SenescenceControl in KSHV
Latent Infection
This figure presents one mechanism of how v-FLIP assists v-cyclin to bypass the cellular senescence
response, allowing v-cyclin-mediated cell hyperproliferation during latent infection of KSHV. v-cyclin,
a latent gene product of KSHV and a homolog of cellular D-type cyclin, drives aberrant cell-cycle progres-
sion in partnership with the cellular cyclin-dependent kinase CDK6, leading to the activation of DNA
damage response (DDR) and p53 checkpoint control. As a result, autophagy is upregulated through
p53-dependent negative regulation of the mTOR signaling axis. Activated autophagy then enables cellular
senescence through currently unknown mechanisms (indicated by a question mark), preventing aberrant
cellular proliferation. To circumvent this antiproliferative barrier, the virus expresses v-FLIP as a ‘‘second
hit’’ to attenuate autophagy-associated cellular senescence, acting directly on the autophagy machinery
by inhibiting Atg3. v-FLIP can also activate the NF-kBpathway, extending the life span of infected cells. As
a result, virally infected cells continue to grow and divide in an unregulated manner as genetic errors accu-
mulate, establishing favorable conditions for neoplastic transformation.
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(Leidal et al., 2012). They propose that
the virus must use a mechanism to inacti-
vate this failsafe program in addition to
the effects it exerts through v-cyclin. The
authors investigated which latency gene,
when expressed, overcomes the senes-
cence barrier in primary human foreskin
fibroblasts (HFFs) expressing v-cyclin.
This led to the identification of v-FLIP as
a specific and potent repressor of v-cyclin
OIS (Figure 1). How does v-FLIP attenuate
v-cyclin-triggered OIS? One possibility
is that v-FLIP and v-cyclin may share
the same molecular target, but have
opposing effects on its activity. Alterna-
tively, v-FLIP and v-cyclin may function
in independent and opposing signaling
pathways to complement the actions of
each other. Leidal et al. now provide
compelling evidence that autophagy102 Cell Host & Microbe 11, February 16, 201constitutes such a shared target and is
a critical mediator of v-cyclin-induced
senescence, which is successfully coun-
tered by v-FLIP for the virus to be
pathogenic.
In this work, the authors discovered
that, following induction of v-cyclin, the
oncogenic stress sensed by the cells
activated p53 and triggered a strong
autophagic response. Subsequently, the
v-cyclin-insulted cells became senes-
cent, accompanied by the secretion of
various cytokines that are thought to
help establish OIS. Removing p53 or
knocking down autophagy resulted in
a bypass of senescence and resumed
growth of v-cyclin-expressing cells, which
is reminiscent of the effects of oncogenic
ras. Although this might not be an unex-
pected finding, it nevertheless suggests
that activating autophagy may be2 ª2012 Elsevier Inc.a common event for cells to elicit a ‘‘self-
disabling’’ process induced by RAS or on-
coviruses, again highlighting the impor-
tance of autophagy in counteracting
malignancies. It is important to note that
the authors have demonstrated that
v-cyclin-induced autophagy occurs in
a p53-dependent manner. The increased
expression of the p53 target genes,
particularly Sestrin1, switched off the
mTOR signaling axis, a master inhibitor
of autophagy, and consequently elicited
the autophagy cascade. These results
are in agreement with a negative feed-
back loop that reportedly occurs during
RAS-mediated senescence (Gorgoulis
and Halazonetis, 2010).
Considering that v-cyclin induces
a state of increased proliferation that is
kept in check by a concomitant increase
in autophagy and senescence in normal
cells, the finding (Leidal et al., 2012) that
the virus utilizes v-FLIP as a ‘‘universal
inhibitor’’ of autophagy to release the
brakes on proliferation does not really
come as a surprise. McCormick and
colleagues demonstrate that expression
of v-FLIP successfully antagonized
v-cyclin-induced autophagy and thereof
cellular senescence, albeit with no
discernible effect onDDRs.Usinga v-FLIP
mutant that no longer activates NF-kB but
can still attenuate autophagy, the authors
show that v-FLIP expression continues to
subvert senescence induced by v-cyclin.
However, eliminating the anti-Atg3 activity
of v-FLIP or feeding cells anti-v-FLIP
peptides reactivated antiproliferative
senescence. Their results, in conjunction
with the previous finding (Lee et al.,
2009) that revealed a distinct role of
v-FLIP in mediating the antiautophagic
interaction and NF-kB activation at a
molecular level, also indicate that v-FLIP-
elicited antiautophagy and NF-kB activa-
tion confer distinct actions in KSHV
latency, with autophagy evasion clearly
implicated in restricting senescence to
allow viral-driven proliferation. The
outcome of such a joint action of v-FLIP
and v-cyclin in reshaping autophagy may
synergistically increase the chance of
cancer development and drug resistance
associated with KSHV infection.
After all is said and done, it is worth
noting that the oncogenic interplay of
v-cyclin and v-FLIP reported by Leidal
et al. was largely determined in cultured
cells. Whether it is reflective of what
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virus in human biology awaits further
investigation. Furthermore, v-FLIP likely
antagonizes host autophagy not only to
evade OIS but also to favor viral persis-
tence. From a viral perspective, during
long-term persistent infection wherein
the viral genome is replicated in tight
conjunction with host chromosomal
DNA, reshaping cellular autophagy may
have an active role in antagonizing host
antiviral immune responses, such as
antigen presentation, to allow persis-
tence. From a host perspective, since
autophagy has been implicated in patrol-
ling genomic stability, blunting autophagy
may also render virally infected cells error
prone, an environment more favorable for
viral fitness and survival. Despite our
growing understanding of the molecular
nature of autophagy, how autophagy
enables cells’ self-disabling processremains a question that is currently unan-
swered and is certainly a future challenge.
Nonetheless, the Leidal et al. (2012) work
suggests that evasion of autophagy may
be a shared value for oncogenic viruses
and that technologies that interfere with
viral undermining of host autophagy could
have considerable promise in treating vir-
ally associated malignancies.ACKNOWLEDGMENTS
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The host restriction factor SAMHD1 hinders lentiviral infection of myeloid cells, a function counteracted by
the viral protein Vpx. Two papers in this issue of Cell Host & Microbe document the genetic conflict between
SAMHD1 and the Vpr/Vpx proteins, which has subjected SAMHD1 to intense periods of diversifying selection
through primate evolution.In Lewis Carroll’s book Through the Look-
ing-Glass, the Red Queen says, ‘‘It takes
all the running you can do, to keep in the
same place.’’ Evolutionary biologists
have often used the Red Queen’s race as
a metaphor for the never-ending evolu-
tionary race between a host and a path-
ogen. Cellular proteins that fight viral
infection are subject to constant attack
by their viral counterparts, and they must
continue to evolve and escape in an itera-
tive process leading to coevolution. In the
lentivirus literature a number of innate
immune defense proteins have been
documented, commonly referred to as
‘‘restriction factors’’ (reviewed in Malimand Emerman, 2008). The sterile alpha
motif (SAM) domain and histidine/aspartic
acid domain (HD)-containing protein 1
(SAMHD1) is the most recent addition to
the list of restriction factors that act
against lentiviruses (Hrecka et al., 2011;
Laguette et al., 2011), thus joining APO-
BEC3G, TRIM5a, and tetherin (Malim and
Emerman, 2008).Correspondingly, lentivi-
ral ‘‘accessory’’ proteins such asNef, Vpu,
and Vpx have been identified to overcome
the effect of restriction factors. Specifi-
cally, while SAMHD1 effectively restricts
HIV-1 replication, Vpx from HIV-2 and
related simian immunodeficiency viruses
(SIVsmm/mac) counteract the restrictivemechanism by promoting proteasome-
dependent degradation of SAMHD1
(Hrecka et al., 2011; Laguette et al., 2011).
SAMHD1was recently shown to convert
deoxynucleoside tryphosphates (dNTP)
into deoxynucleosides and inorganic try-
phosphate, thus controlling intracellular
levels of dNTPs, the substrates for reverse
transcription (Goldstone et al., 2011). The
levels of dNTPs are limiting in nondividing
cells such as macrophages and dendritic
cells—approximately 200-fold lower than
in activated T cells (Diamond et al.,
2004)—in part due to SAMHD1’s activity.
Low levelsofdNTPs fail to support efficient
viral reverse transcription.February 16, 2012 ª2012 Elsevier Inc. 103
